Raymond James & Associates’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-762
| Closed | -$153K | – | 3498 |
|
|
2018
Q1 | $153K | Sell |
762
-554
| -42% | -$111K | ﹤0.01% | 3180 |
|
|
2017
Q4 | $189K | Buy |
1,316
+116
| +10% | +$16.7K | ﹤0.01% | 3055 |
|
|
2017
Q3 | $198K | Sell |
1,200
-1,345
| -53% | -$222K | ﹤0.01% | 3029 |
|
|
2017
Q2 | $345K | Buy |
2,545
+1,156
| +83% | +$157K | ﹤0.01% | 2628 |
|
|
2017
Q1 | $267K | Buy |
+1,389
| New | +$267K | ﹤0.01% | 2751 |
|